Corbus Pharmaceuticals Holdings, Inc. Contracts & Agreements

Form of Restricted Stock Unit Award Agreement (Filed With SEC on May 20, 2024)

Form of Restricted Stock Award Agreement (Filed With SEC on May 20, 2024)

Corbus Pharmaceuticals Holdings, Inc. 2024 Equity Compensation Plan (Filed With SEC on May 20, 2024)

Form of Incentive Stock Option Grant Agreement (Filed With SEC on May 20, 2024)

Form of Non-Statutory Stock Option Grant Agreement (Filed With SEC on May 20, 2024)

Form of Fifth Amended and Restated Employment Agreement between Corbus Pharmaceuticals Holdings, Inc. and Yuval Cohen (Filed With SEC on April 10, 2024)

Form of Sixth Amended and Restated Employment Agreement between Corbus Pharmaceuticals Holdings, Inc. and Sean Moran (Filed With SEC on April 10, 2024)

Schedule 1 Definitions and interpretation (Filed With SEC on March 12, 2024)

Underwriting Agreement, dated January 31, 2024 (Filed With SEC on February 1, 2024)

Amendment to Loan Agreement (Filed With SEC on October 31, 2022)

Form of Fifth Amended and Restated Employment Agreement between Corbus Pharmaceuticals Holdings, Inc. and Sean Moran (Filed With SEC on April 15, 2022)

Form of Fourth Amended and Restated Employment Agreement between Corbus Pharmaceuticals Holdings, Inc. and Yuval Cohen (Filed With SEC on April 15, 2022)

Form of Second Amended and Restated Employment Agreement between Corbus Pharmaceuticals Holdings, Inc. and Craig Millian (Filed With SEC on April 15, 2022)

Employment Agreement between the Company and Rachael Brake, effective as of December 6, 2021 (Filed With SEC on March 8, 2022)

Description of Capital Stock (Filed With SEC on March 8, 2022)

Amendment to Employment Agreement between Corbus Pharmaceuticals Holdings, Inc., and Craig Millian, effective as of September 27, 2021 (Filed With SEC on September 28, 2021)

Separation and General Release Agreement between the Company and Barbara White, dated September 17, 2021 (Filed With SEC on September 22, 2021)

License Agreement, dated May 26, 2021, between Corbus Pharmaceuticals, Inc. and The Regents of the University of California (Filed With SEC on August 12, 2021)

License Agreement, dated May 25, 2021, between Corbus Pharmaceuticals, Inc. and Milky Way BioPharma, LLC (Filed With SEC on August 12, 2021)

Separation and Release Agreement between the Company and Robert Discordia, dated November 30, 2020 (Filed With SEC on December 4, 2020)

Open Market Sale AgreementSM, dated August 6, 2020, by and between the Registrant and Jefferies LLC (Filed With SEC on August 6, 2020)

Loan and Security Agreement, dated as of July 28, 2020, by and between Corbus Pharmaceuticals Holdings, Inc., Corbus Pharmaceuticals, Inc., K2 Healthventures LLC and Ankura Trust... (Filed With SEC on July 29, 2020)

Form of Warrant to Purchase Common Stock (Filed With SEC on July 29, 2020)

Amended and Restated Employment Agreement between Corbus Pharmaceuticals Holdings, Inc. and Robert Discordia, effective as of April 11, 2020 (Filed With SEC on May 11, 2020)

Amended and Restated Employment Agreement between Corbus Pharmaceuticals Holdings, Inc. and Craig Millian, effective as of April 11, 2020 (Filed With SEC on May 11, 2020)

Fourth Amended and Restated Employment Agreement between Corbus Pharmaceuticals Holdings, Inc. and Sean Moran, effective as of April 11, 2020 (Filed With SEC on May 11, 2020)

Second Amended and Restated Employment Agreement between Corbus Pharmaceuticals Holdings, Inc. and Barbara White, effective as of April 11, 2020 (Filed With SEC on May 11, 2020)

Third Amended and Restated Employment Agreement between Corbus Pharmaceuticals Holdings, Inc. and Yuval Cohen, effective as of April 11, 2020 (Filed With SEC on May 11, 2020)

Form of Third Amended and Restated Employment Agreement between Corbus Pharmaceuticals Holdings, Inc. and Sean Moran (Filed With SEC on April 1, 2020)

Form of Second Amended and Restated Employment Agreement between Corbus Pharmaceuticals Holdings, Inc. and Yuval Cohen (Filed With SEC on April 1, 2020)

Form of Second Amended and Restated Employment Agreement between Corbus Pharmaceuticals Holdings, Inc. and Barbara White (Filed With SEC on April 1, 2020)

Description of Capital Stock (Filed With SEC on March 16, 2020)

Underwriting Agreement, dated February 7, 2020 (Filed With SEC on February 7, 2020)

Lease Amendment No. 2 dated as of October 25, 2019, among River Ridge Limited Partnership, Corbus Pharmaceuticals, Inc. and Corbus Pharmaceuticals Holdings, Inc (Filed With SEC on November 7, 2019)

Consulting Agreement between Corbus Pharmaceutical Holdings, Inc. and Mark Tepper, dated March 31, 2019 (Filed With SEC on April 1, 2019)

Separation Agreement between Corbus Pharmaceutical Holdings, Inc. and Mark Tepper, dated March 31, 2019 (Filed With SEC on April 1, 2019)

Offer Letter, dated as of February 19, 2019, between Craig Millian and Corbus Pharmaceuticals, Inc (Filed With SEC on March 12, 2019)

Lease Amendment No. 1, dated as of February 26, 2019, among River Ridge Limited Partnership, Corbus Pharmaceuticals, Inc. and Corbus Pharmaceuticals Holdings, Inc (Filed With SEC on March 12, 2019)

Underwriting Agreement, dated January 25, 2019 (Filed With SEC on January 25, 2019)

Collaboration and License Agreement, dated January 3, 2019, between Corbus Pharmaceuticals, Inc. and Kaken Pharmaceutical Co., Ltd (Filed With SEC on January 3, 2019)

License Agreement, dated as of September 20, 2018, between Corbus Pharmaceuticals, Inc. and Jenrin Discovery, LLC (Filed With SEC on November 8, 2018)

Amended and Restated Employment Agreement between Corbus Pharmaceuticals Holdings, Inc. and Yuval Cohen, dated April 11, 2018 (Filed With SEC on April 13, 2018)

Amended and Restated Employment Agreement between Corbus Pharmaceuticals Holdings, Inc. and Mark Tepper, dated April 11, 2018 (Filed With SEC on April 13, 2018)

Amended and Restated Employment Agreement between Corbus Pharmaceuticals Holdings, Inc. and Barbara White, dated April 11, 2018 (Filed With SEC on April 13, 2018)

Amended and Restated Employment Agreement between Corbus Pharmaceuticals Holdings, Inc. and Sean Moran, dated April 11, 2018 (Filed With SEC on April 13, 2018)

Cystic Fibrosis Program Related Investment Agreement, dated January 26, 2018, between Cystic Fibrosis Foundation Therapeutics, Inc. and the Company (Filed With SEC on March 12, 2018)

Warrant to Purchase Common Stock, dated as of January 26, 2018, issued to the Cystic Fibrosis Foundation (Filed With SEC on March 12, 2018)

Underwriting Agreement, dated October 24, 2017 (Filed With SEC on October 24, 2017)

GU A R A N T E E (Filed With SEC on August 22, 2017)

LEASE (Filed With SEC on August 22, 2017)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on February 28, 2017)

CORBUS PHARMACEUTICALS HOLDINGS, INC. Shares of Common Stock (par value$0.0001 per share) Controlled Equity OfferingSM Sales Agreement (Filed With SEC on November 23, 2016)

LEASE (Filed With SEC on November 10, 2016)

FIRSTAMENDMENT TO LEASE (Filed With SEC on November 10, 2016)

SECONDAMENDMENT TO LEASE (Filed With SEC on November 10, 2016)

THIRDAMENDMENT TO LEASE (Filed With SEC on November 10, 2016)

AGREEMENTBETWEEN ORCHESTRA MEDICAL VENTURES, LLC AND CORBUS PHARMACEUTICALSHOLDINGS, INC. (Filed With SEC on September 21, 2016)

EXHIBIT 10.1 SECURITIES PURCHASE AGREEMENT (Filed With SEC on June 10, 2016)

AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT (Filed With SEC on April 15, 2016)

EMPLOYMENT AGREEMENT (Filed With SEC on April 15, 2016)

AMENDMENT NO. 1 TO AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on April 15, 2016)

AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT (Filed With SEC on April 15, 2016)

CORBUS PHARMACEUTICALS HOLDINGS, INC. WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on January 5, 2015)

INDEMNIFICATIONAGREEMENT (Filed With SEC on September 30, 2014)

AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on September 3, 2014)

SUBSCRIPTION (Filed With SEC on September 3, 2014)

SUBSCRIPTION AGREEMENT (Filed With SEC on September 3, 2014)

AGREEMENT AND PLAN OF MERGER by and among CORBUSPHARMACEUTICALS Holdings, Inc, cORBUSpHARMACEUTICALS ACQUISITION, Inc., and JB THERAPEUTICS, INC. (Filed With SEC on September 3, 2014)

CORBUS PHARMACEUTICALS HOLDINGS, INC. WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on September 3, 2014)

EMPLOYMENT AGREEMENT (Filed With SEC on September 3, 2014)

RestrictedStock Agreement CORBUS PHARMACEUTICALS HOLDINGS, INC. (Filed With SEC on September 3, 2014)

NONQUALIFIED STOCK OPTION GRANT AGREEMENT CORBUS PHARMACEUTICALS HOLDINGS, INC. (Filed With SEC on September 3, 2014)

INCENTIVE STOCK OPTION GRANT AGREEMENT CORBUS PHARMACEUTICALS HOLDINGS, INC. (Filed With SEC on September 3, 2014)

CORBUS PHARMACEUTICALS HOLDINGS, INC. 2014 EQUITY COMPENSATION PLAN (Filed With SEC on September 3, 2014)

VOTINGAGREEMENT (Filed With SEC on September 3, 2014)

SUBSCRIPTION AGREEMENT (Filed With SEC on September 3, 2014)

AGREEMENT BETWEEN ORCHESTRA MEDICALVENTURE, LLC AND CORBUS PHARMACEUTICALS HOLDINGS, INC. (Filed With SEC on September 3, 2014)

PLACEMENT AGENCY AGREEMENT (Filed With SEC on September 3, 2014)

RegistrationRights Agreement (Filed With SEC on September 3, 2014)

CORBUS PHARMACEUTICALS HOLDINGS, INC. WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on September 3, 2014)

Category

Industry

Companies

Contracts

Corbus Pharmaceuticals Holdings, Inc. Contracts & Agreements